Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

L'Oreal FY11 Profit Rises - Quick Facts

L'Oreal SA (LRLCY.PK) Monday reported an increase in profit for the full-year 2011, as sales and gross margins improved.

Net profit excluding non-recurring items after non-controlling interests for the full-year 2011 improved to 2.58 billion euros or 4.32 euro per share from 2.37 billion euros or 4.01 euro per share last year.

Net profit after non-controlling interests for the period was 2.44 billion euros or 4.08 euro per share compared to 2.24 billion euros or 3.79 euro per share last year.

Sales for the full-year rose to 20.34 billion euros from 19.50 billion euros last year. On a like-for-like basis, sales for the year increased 5.1 percent from last year.

Full-year gross margin advanced 40 basis points to 71.2 percent.

Click here to receive FREE breaking news email alerts for L'Oreal Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.